BioCryst Pharmaceuticals stock price
바이오크리스트 파머슈티컬스NASDAQ:BCRX · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →BioCryst Pharmaceuticals last closed at $8.17 (+0.62%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -5.6×. Its overall grade ranks 13 of 739 stocks in Healthcare.
About this company
BioCryst Pharmaceuticals last closed at $8.17 (+0.62%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 13/739
Valuation grade B+
Related stocks
- Takeda PharmaceuticalCustomer
안젤엠(hereditary angioedema) 시장에서 경쟁·대체 치료제로 연결
- CSL BehringCompetitor
유전성 혈관부종(HAE) 치료제 핵심 경쟁사
- RocheCompetitor
항바이러스·희귀질환 영역에서 유사 치료제 경쟁 가능
About BioCryst Pharmaceuticals
- What technical signals does BioCryst Pharmaceuticals (BCRX) have?
- BioCryst Pharmaceuticals current technical signals: no active technical signal.
- Is BioCryst Pharmaceuticals a cup-and-handle pattern?
- No. BioCryst Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for BioCryst Pharmaceuticals?
- Market cap: $1.72B. Trailing 12 months PER: -5.6×. Latest quarter PBR: -4.77×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about BioCryst Pharmaceuticals, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).